Zobrazeno 1 - 10 of 42 pro vyhledávání: '"Francisco Dário, Rocha Filho"'
1
Akademický článek
Presence of new mutations in the TP53 gene in patients with low-risk myelodysplastic syndrome: two case reports
Autor: Fernando Barroso Duarte, Romélia Pinheiro Gonçalves Lemes, Talyta Ellen de Jesus dos Santos, Maritza Cavalcante Barbosa, João Paulo Leitão de Vasconcelos, Francisco Dário Rocha-Filho, Ilana Zalcberg, Diego Coutinho, Monalisa Feliciano Figueiredo, Luciana Barros Carlos, Paulo Roberto Leitão de Vasconcelos
Publikováno v: Journal of Medical Case Reports, Vol 11, Iss 1, Pp 1-4 (2017)
Abstract Background Myelodysplastic syndromes are heterogeneous disorders. Patients with myelodysplastic syndrome disease often have ineffective hematopoiesis, cytopenias, blood cell dysplasia in one or more cell types, and are at high risk for devel
Externí odkaz: https://doaj.org/article/1547248c55654b82b8a9a6b0eaf372b1
Zobrazit plný text záznamu
2
Akademický článek
Tumor suppressor p53 protein expression: prognostic significance in patients with low-risk myelodysplastic syndrome
Autor: Fernando Barroso Duarte, Romelia Pinheiro Gonçalves, Maritza Cavalcante Barbosa, Francisco Dário Rocha Filho, Talyta Ellen de Jesus dos Santos, Thayna Nogueira dos Santos, Paulo Roberto Leitão de Vasconcelos
Publikováno v: Revista Brasileira de Hematologia e Hemoterapia, Vol 36, Iss 3, Pp 196-201 (2014)
BACKGROUND: At the time of diagnosis, more than 50% of patients with myelodysplastic syndrome have a normal karyotype and are classified as having a favorable prognosis. However, these patients often show very variable clinical outcomes. Furthermore,
Externí odkaz: https://doaj.org/article/127d8664729544a98ceddd964a053a7c
Zobrazit plný text záznamu
4
Akademický článek
Doença de Rosai-Dorfman cutânea Cutaneous Rosai-Dorfman Disease
Autor: Fábio Machado Landim, Helena de Oliveira Rios, Carolina Oliveira Costa, Roney Gonçalves Fechine Feitosa, Francisco Dário Rocha Filho, Adriana Alencar Araújo Costa
Publikováno v: Anais Brasileiros de Dermatologia, Vol 84, Iss 3, Pp 275-278 (2009)
Doença de Rosai-Dorfman é uma doença benigna e autolimitada. Tem etiologia desconhecida e foi descrita pela primeira vez por Rosai e Dorfman em 1969. As manifestações clássicas incluem linfadenopatia cervical usualmente acompanhada por febre, l
Externí odkaz: https://doaj.org/article/3dabcefc7f4c4bdab096b53568afc899
Zobrazit plný text záznamu
5
Akademický článek
Influência do CD 20 na refratariedade do linfoma de Hodgkin clássico ao tratamento inicial com o esquema ABVD, no Ceará, Brasil Influence of CD 20 antigen expression in the refractoriness of classical Hodgkin lymphoma in the first line treatment with ABVD protocol in Ceará state, Brazil
Autor: Rogério Pinto Giesta, Francisco Dário Rocha Filho, Francisco Valdeci de Almeida Ferreira, Acy Telles de Souza Quixadá, Jorg Heukelbach, Marília de Andrade Guedes Giesta
Publikováno v: Jornal Brasileiro de Patologia e Medicina Laboratorial, Vol 45, Iss 3, Pp 247-252 (2009)
INTRODUÇÃO: A significância prognóstica do marcador imunológico CD 20 no linfoma de Hodgkin clássico (LHc) ainda é incerta, particularmente no que se refere à refratariedade ao tratamento inicial. OBJETIVOS: Avaliar a influência da positivid
Externí odkaz: https://doaj.org/article/01f70a9d227740c99c03fbc6989161f0
Zobrazit plný text záznamu
7
Akademický článek
Simultaneous occurrence of follicular lymphoma and mixed-cellularity Hodgkin's lymphoma: lymph node and extranodal involvement
Autor: Maria do Patrocínio F. Grangeiro, Sílvia Maria M. Magalhães, Francisco Valdeci A. Ferreira, Francisco Dário Rocha Filho
Publikováno v: Jornal Brasileiro de Patologia e Medicina Laboratorial, Vol 40, Iss 1, Pp 33-36 (2004)
An unusual and well-characterised case of composite lymphoma in the spleen and lymph node is presented. The simultaneous occurrence of mixed-cellularity Hodgkin's lymphoma (HL) and follicular non-Hodgkin's lymphoma (NHL) was demonstrated in a 66-year
Externí odkaz: https://doaj.org/article/fadc7bd85c254d19b433c65703c82ba4
Zobrazit plný text záznamu
8
Use of checkpoint inhibitors in gray zone lymphoma
Autor: Ricardo Vale Albino Oliveira Filho, João Paulo de Vasconcelos Leitão, Naiana Castelo Branco Campos, Juliene Lima Mesquita, Francisco Dário Rocha Filho, Fernando Barroso Duarte, Yhasmine Delles Oliveira Garcia, Romélia Pinheiro Gonçalves Lemes, Fernando Ricardo Fernandes Paz, Yensy Mariana Zelaya Rosales
Publikováno v: Hematology/Oncology and Stem Cell Therapy.
Checkpoint inhibitors, cancer immunotherapies, are the new forms of treatment for gray zone lymphoma, a rare subtype that combines the characteristics of both Hodgkin and non-Hodgkin disease forms. Programmed cell death protein 1/programmed cell deat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e0fbf792cc0ab5e818d81d84edc79e47
https://doi.org/10.1016/j.hemonc.2020.06.001
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje